share_log
Breakings ·  Nov 7 21:08
PMV Pharmaceuticals: Cash, Cash Equivalents, & Marketable Securities of $197.9 Mln as Sept 30, Providing Expected Cash Runway to End of 2026
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment